Dr. med. Jesica Mazza-Stalder

Vice president of Vaud Lung League

Medical Officer of Public Health for tuberculosis VD (Tuberculosis 10%)

Medical Advisor in Respiratory Medicine at the Vaud Lung League (10%)

Senior consultant at the Division of Respiratory Medicine (30%) University Hospital of Lausanne Switzerland (CHUV) and private practice in Pulmonary Medicine at Nyon (60% of activity)

Chief of Residents, Respiratory Division CHUV

Chief of Residents (Chef de Clinique) Thoracic Surgery Division CHUV

Respiratory Medicine as MD at University Hospital of Geneva

Respiratory Medicine training as a resident (MD) at Rolle Hospital

Respiratory Medicine Residency (resident)  at CHUV

Chief of Residents and residency of Internal Medicine Central Military Hospital

Member of the Board Swiss TB

Vice President of Lung League Vaud 

International Union against Tuberculosis and Lung disease

Swiss Respiratory Society

European Respiratory Society

Federal Swiss Diploma

Doctorate Unil University of Lausanne Switzerland

FMH Respiratory Medicine

Internal Medicine Specialist (Buenos Aires- Argentina)

Medical Doctor education Faculty of Medicine Buenos Aires University (UBA)

Tadolini, GB Miggliori et al Eur Respir J may 2020
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

Borisov S, et al….Mazza-Stalder J, Nicod LP, Miggliori GB Eur Respir J 2019 Dec 19,54 (6) Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

J Mazza-Stalder, E Chevallier, O Opota, A Carreira, K Jaton, E Masserey, J P Zellweger, L P Nicod. Frontiers in Medicine. Published June 2019. Improvement in tuberculosis outcomes with a combined medical and social approach

Opota O, Mazza-Stalder J, Greub G, Jaton K.  The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection. Clinic Microbiol Infection 2019 Nov  doi: 10.1016/j.cmi.2019.03.021. Epub 2019 Mar 28

Zakham F1, Laurent S1, Esteves Carreira AL2, Corbaz A2, Bertelli C1, Masserey E3, Nicod L2, Greub G1, Jaton K1, Mazza-Stalder J2, Opota O1. New Microbes New Infect. 2019 Jun 29; 31:100582. doi: 0.1016/j.nmni.2019.100582. eCollection 2019 Sep. Whole-genome sequencing for rapid, reliable and routine investigation of Mycobacterium tuberculosis transmission in local communities

Simon A, Opota O, Mazza-Stalder J, Nicod L, Greub G, Nicod L, Jaton K. Added diagnostic value of 16S rRNA gene pan mycobacterial for nontuberculous mycobacterial infections: a 10 year retrospective study

O Opota, F Zakham, J Mazza-Stalder, L Nicod, G Greub, K Jaton. Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low Prevalence Setting. J Clin Microbiol 2018 57:e01717-18

Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD, van der Werf MJ, and the MDR-TB Cluster Consortium. A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. Lancet Infect Dis. 2018;18(4):431-40

Opota O, Senn L, Prod'hom G, Mazza Stalder J, Tissot F, Greub G, Jaton K. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country. Clin Microbiol Infect. 2016 Jul;22(7):613-9. doi: 10.1016/j.cmi.2016.04.010. Epub 2016 Apr 29

Stucki D, Ballif M, Egger M, Furrer H, Altpeter E, Battegay M, Droz S, Bruderer T, Coscolla M, Borrell S, Zürcher K, Janssens JP, Calmy A, Mazza Stalder J, Jaton K, Rieder HL, Pfyffer GE, Siegrist HH, Hoffmann M, Fehr J, Dolina M, Frei R, Schrenzel J, Böttger EC, Gagneux S, Fenner L. Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country.J Clin Microbiol. 2016 Jul;54(7):1862-70. doi: 10.1128/JCM.00126-16.

Rozot V, Amelio P, Vigano S, Mazza-Stalder J, Idrizi E, Day Cheryl, Perreau M, Lazor-Blanchet C, Ohmiti K, Goletti D, Bart P. A, Hanekom W, Scriba Th, Nicod L, Pantaleo G et Harari A. Clinical infectious disease 2015. Combined Use of M Tuberculosis-specific CD4 and CD8 T cell is a Powerful Diagnostic tool of Active Tuberculosis

Bridevaux P-O, Aubert J-D, Soccal P M, Mazza-Stalder J, Berutto C, Rochat T, Turin L, Van Belle, Nicod L. P et al Thorax september 2013 Incidence and Outcomes of respiratory viral infections in lung transplant recipients: a prospective study

Perreau M, Rozot V, Welles HC, Belluti-Enders F, Vigano S, Maillard M, Dorta G, Mazza-Stalder J, Bart PA, Roger T, Calandra T, Nicod L, Harari A. Eur J Immunol. 2013 Apr; 43(4):939-48. Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+T cells in active disease

Rozot V, Mazza-Stalder J, Nicod L. P, Harari A. et al EJI 2013. Mycobacterium tuberculosis-specific CD8+ T Cells are functionally and phenotypically different between latent infection and active disease

Mazza-Stalder J, Nicod L., Janssens JP. Revue des Maladies respiratoires avril 2012. La tuberculose extra-pulmonaire

Harari A, R Rozot V, Bellutti Enders F,  Perreau M,  Mazza-Stalder J,  Nicod L., Cavassini M,  Calandra Th, Lazor Blanchet K, Jaton K,  Faouzi M, Day Ch, Willem A. Hanekom, Bart P-A and  Pantaleo G. Nature Med 2011. Dominant TNF-a Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses Discriminate Between Latent Infection and Active Disease

Uçkay I, Gasche-Soccal PM, Kaiser L, Stern R, Mazza-Stalder J, Aubert JD, van Delden C. J Heart Lung Transplant. 2010 Mar; 29(3):299-305. Epub 2009 Oct 17. Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy

Boillat Blanco N, Kuonen R, Bellini C, Manuel O, Estrade C, Mazza-Stalder J, Aubert JD, Sahli R, Meylan P. Transpl Infect Dis. 2010 Aug 30. Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient

Mazza-Stalder J, Lador F, Soccal-Gasche P, Aubert J. Evaluation of pulmonary arterial pressure in lung transplant candidates: transthoracic echocardiographie versus right heart catheterization. « Meilleur poster à la Société suisse d’hypertension pulmonaire ». ERS Vienna 2009/ and 4th International Congress of the Swiss Society for Pulmonary Hypertension. SSPH Zurich 2009: Best Poster

Mazza-Stalder J, Janton-Ogay K, Nicod L. Revue medicale Suisse nov 2009. Non tuberculous mycobacteria pulmonary disease: what's new? 

Mazza-Stalder J, Sistek, J. P. Revelly, S. D. Qanadli, A. Sauty. Massive haemoptysis in cystic fibrosis adult patients. ERS 2008. P1244. 5.10.2008

Mazza-Stalder J, Siegrist CA, Janssens JP. Rev Med Suisse. 2005 Nov 16; 1(41):2645-6, 2649-51. Immunization and immuno-modulation for prevention of respiratory tract infections

Mazza-Stalder J, Sauty A. 48h-continuous interstitial glucose monitoring in non-diabetic cystic fibrosis patients: a pilot study. Journal of Cystic Fibrosis 2 (suppl1), pp. S79, 2003

Mazza-Stalder J, Sauty A. Le syndrome hépatopulmonaire (SHP). Médecine et hygiène 2458, 12 nov 2003

Mazza-Stalder J, Sauty A. Significance of macrophage predominance in pleural effusions. Oral presentation ERS congress Schweiz Med Forum suppl 7, pp 20S 2002